Login / Signup

Randomized, Controlled Study of Opicapone in Japanese Parkinson's Patients with Motor Fluctuations.

Atsushi TakedaRyosuke TakahashiYoshio TsuboiMasahiro NomotoTetsuya MaedaAkihisa NishimuraKazuo YoshidaNobutaka Hattori
Published in: Movement disorders : official journal of the Movement Disorder Society (2020)
In Japanese patients, both opicapone 25 and 50 mg were significantly more effective than placebo with no dose-dependent difference in efficacy, and both doses were well tolerated. © 2020 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Keyphrases
  • double blind
  • phase iii
  • placebo controlled
  • open label
  • clinical trial
  • phase ii
  • randomized controlled trial
  • study protocol